|
|
|
4. Ustekinumab dosing individualization in Crohn's disease guided by a population pharmacokinetic-pharmacodynamic modelJurij Zdovc, Jurij Hanžel, Borut Štabuc, Tomaž Vovk, Barbara Ostanek, David Drobne, Iztok Grabnar, 2021, original scientific article Keywords: ustekinumab, inflammatory bowel disease, fecal calprotectin, pharmacokinetics-pharmacodynamics, therapeutic drug monitoring Full text (file, 1,20 MB) This document has more files! More... |
5. Pathology of fibrosis in Crohn's disease - contribution to understanding its pathogenesisNina Zidar, Cord Langner, Miha Jerala, Emanuela Boštjančič, David Drobne, Aleš Tomažič, 2020, original scientific article Keywords: Crohn's disease, fibrosis, stenosis, pathology, pathogenesis Full text (file, 2,76 MB) This document has more files! More... |
6. Comparison of 3 enzyme-linked immunoassay methods to evaluate serum concentrations of infliximab and antibodies to infliximab in 32 patients with moderate to severe inflammatory bowel diseaseTomislav Jukić, David Drobne, Saša Pušavec, Alojz Ihan, David Štubljar, Andrej Starc, 2023, original scientific article Keywords: antibodies, enzyme-linked immunosorbent assay, infliximab, materials testing Full text (file, 286,74 KB) This document has more files! More... |
7. Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activityArmando Tratenšek, Igor Locatelli, Iztok Grabnar, David Drobne, Tomaž Vovk, 2024, original scientific article Keywords: inflammatory bowel disease, ulcerative colitis, Crohn's disease, oxidative stress, biomarker, meta-analysis Full text (file, 5,83 MB) This document has more files! More... |
|
9. Določanje nivoja anti-TNF bioloških zdravil in nastajanja protiteles proti zdravilu med zdravljenjem kronične vnetne črevesne bolezniSaša Pušavec, 2017, master's thesis Keywords: črevesne bolezni, kronična vnetna črevesna bolezen, zdravljenje, biološka zdravila, anti-TNF, infliksimab, imunokemijske metode, ELISA Full text (file, 2,36 MB) |
|